Search Results 81-90 of 17513 for Assay
Neuropharmacological assay for drug development. Dr. Choi's lab develops neurobiological treatment methods for alcohol use disorder and related psychiatric ...
... assay development of various types of disorders. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...
... assays to those obtained by orthogonal methods, including tissue-based assays and results from a ctDNA assay by Guardant on blood. Defining the Immunologic ...
Eligible participants with mCRC will be enrolled into specific treatment arms based on their biomarker assay results. ... assays and results from a ctDNA assay by ...
Diagnosis · MOG antibody testing with a cell-based assay. This test looks at cells with MOG on their surface to see if the MOG -antibody is present in the blood.
The purpose of this study is to collect biological samples (whole blood and saliva) to develop and validate a genotype assay for Autosomal Dominant Polycystic ...
Rochester, Minn. The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different ...
Research and development. Upon request, the Targeted Biomarker Core can test most assays or kits available on its current platforms. For novel assay development ...
Since going live in mid-June, Mayo Clinic Laboratories' SRA is on track to be ordered nearly 3,000 times annually. The popularity of the assay reflects the need ...
... assay for the detection of mutations associated with uveal melanoma. The performance characteristics of the ddPCR assay for the detection of ctDNA mutation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.